- Home
- FRHC vs RGEN Comparison
FRHC vs RGEN Comparison
Compare FRHC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRHC | RGEN |
|---|---|---|
| Founded | N/A | 1981 |
| Country | United States | United States |
| Employees | N/A | 2000 |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.0B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | FRHC | RGEN |
|---|---|---|
| Price | $173.25 | $180.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $167.67 |
| AVG Volume (30 Days) | 81.4K | ★ 853.9K |
| Earning Date | 06-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 79.29 | ★ 286.96 |
| EPS | ★ 0.52 | 0.24 |
| Revenue | ★ $2,191,291,000.00 | $141,236,000.00 |
| Revenue This Year | N/A | $14.30 |
| Revenue Next Year | N/A | $14.52 |
| P/E Ratio | ★ $334.87 | $752.96 |
| Revenue Growth | 6.86 | ★ 35.10 |
| 52 Week Low | $107.98 | $100.99 |
| 52 Week High | $177.15 | $188.73 |
Technical Indicators
Market Signals| Indicator | FRHC | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 59.27 | 62.97 |
| Support Level | $145.61 | $158.15 |
| Resistance Level | $174.21 | $188.73 |
| Average True Range (ATR) | 4.02 | 5.68 |
| MACD | 0.10 | 0.33 |
| Stochastic Oscillator | 72.74 | 94.17 |
Price Performance
Historical ComparisonAbout FRHC Freedom Holding Corp.
Freedom Holding Corp is a holding company with reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other. The majority of revenue is from the Banking segment. Banking segment consists of the operations of Freedom Bank KZ and Freedom Bank TJ. Geographically, operates in Kazakhstan, Armenia, Cyprus, the USA, and others, with maximum revenue from Kazakhstan.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.